Abivax (ABVX) Net Cash Flow (2024 - 2026)
Abivax (ABVX) recorded quarterly Net Cash Flow of $664983.5 in Q1 2026, up 100.76% quarter-over-quarter from -$87.9 million in Q4 2025, and up 101.58% on a YoY basis from $329887.1 in Q1 2025.
Abivax (ABVX) Net Cash Flow (2024 - 2026) Analysis & Trends
Abivax's Net Cash Flow history runs 3 years deep, the most recent figure standing at $664983.5 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 101.58% year-over-year to $664983.5; the TTM figure through Mar 2026 stood at $491.3 million (up 430.49% YoY), while the FY2025 annual figure was $440.0 million, up 473.99% from the prior year.
- Net Cash Flow was $664983.5 for Q1 2026 at Abivax, up from -$87.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $626.0 million in Q3 2025 to a low of -$87.9 million in Q4 2025.
- Historically, Net Cash Flow has averaged $36.7 million across 3 years, with a median of -$41.4 million in 2024.
- Biggest YoY gain for Net Cash Flow was 1527.7% in 2025; the steepest drop was 232.67% in 2025.
- A 3-year view of Net Cash Flow shows it stood at -$41.4 million in 2024, then sank by 112.09% to -$87.9 million in 2025, then jumped by 100.76% to $664983.5 in 2026.
- The last three Net Cash Flow figures came in at $664983.5 (Q1 2026), -$87.9 million (Q4 2025), and $626.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 664,983.53 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | -152.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 664,983.53 |
| Mar 31, 2026 | 664,983.53 |
| Dec 31, 2025 | -87.89 Mn |
| Dec 31, 2025 | -87.89 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Mar 31, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.66 Mn |